Privacy-Focused AI: Swiss company Proton has brought its Lumo assistant to desktop, with connectors for local files and apps. Users can set which actions run automatically, need approval or are blocked; Proton says chats aren’t used to train AI. Digital Identity: A new Swiss initiative seeks to keep government e-ID voluntary and guarantee alternatives for accessing services. Organizers have until May 2028 to gather 100,000 signatures for a national vote. Swiss Tech in Practice: Zurich-based Luware says its Teams contact-centre platform helped Dutch housing provider Kleurrijk Wonen cut dropped calls by 15%. Research and Innovation: During Qatar’s state visit to Bern, both countries signaled interest in deeper cooperation in scientific research, technology and innovation.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Privacy-Focused AI: Swiss company Proton launched Lumo Desktop for Windows, macOS and Linux. Its AI assistant can work with files and apps, with users controlling what it can access. Glacier Research: ETH Zurich researchers showed how a fiber-optic cable can detect tiny icequakes and map hidden cracks inside glaciers, offering a simpler way to assess collapse risks. Neurotechnology: Swiss neurotech firm Indivi acquired Cogitat to advance AI-powered brain monitoring. Medical Electronics: Cicor and research centre CSEM agreed to collaborate on medical electronics. Digital ID: Opponents of Switzerland’s e-ID launched a popular initiative seeking to guarantee access to services without a digital ID.
Digital Identity: Opponents of Switzerland’s e-ID have launched a popular initiative seeking to guarantee access to public services without the digital credential; they need 100,000 signatures by May 2028 to trigger a vote. Swiss Pharma: Roche’s breast cancer pill Wilserdly won FDA clearance for some patients with ESR1-mutated, ER-positive, HER2-negative disease. Precision Optics: Swiss firm FISBA has broken ground on a Bulgarian facility to make optical components for surgical-robotics company Intuitive, with production planned for 2028. Quantum Research: Researchers including IBM Research Zurich have observed a room-temperature supersolid, a rare state combining crystal-like order with frictionless flow. Space Technology: ABB will develop a sensitive spectrometer for the Canadian Space Agency to detect methane and other trace gases on Mars.
Swiss Biotech: Basel-based Windward Bio closed an IPO and private placement raising about $251 million to develop long-acting antibody medicines. Roche also won a positive EU committee recommendation for Gazyva as an add-on treatment for lupus. Public Health: Swiss authorities are investigating whether a Listeria strain found at Strähl Käse is linked to recent illnesses; sequencing at the University of Zurich identified a possible connection, but inquiries continue. Research: Scientists from Nestlé Research in Lausanne found notable differences in breast-milk fatty acids and gangliosides across nine countries. Autonomous Systems: Switzerland is testing autonomous urban-logistics systems, while Zurich Airport plans trials of self-driving wheelchairs.
Cloud Infrastructure: Digital Realty has added Zurich to its private connection service for OVHcloud, giving businesses a direct, secure link to European cloud services. Autonomous Mobility: Switzerland is testing self-driving wheelchairs at Zurich Airport and autonomous urban logistics systems. Mental Health Tech: Geneva’s Wyss Center has welcomed MindMetrix, an ETH Zurich spinout using eye measurements to track brain arousal and provide real-time biofeedback; the approach has been tested in more than 100 people. Deep Tech Funding: Swiss companies were among the leading national groups in the European Innovation Council’s selection of 35 deep-tech firms for proposed grants totalling €84 million. Medical Robotics: ETH Zurich researchers are developing magnetic microrobots to deliver clot-dissolving drugs. Early pig tests found clots dissolved about 10 times faster than with medication alone; safety testing is still ahead.
Diagnostics: St Gallen-based Biosynth is expanding its materials for diagnostic tests, including more consistent alternatives to animal-derived reagents, to help developers improve assay performance and supply reliability. Neurotechnology: ETH Zurich researchers helped use AI to fine-tune a brain implant’s signals in one blind participant. The test improved stimulation precision but did not restore sight. Clean Tech: A Swiss study reports electric machinery produces 87% fewer emissions than conventional equipment. Swiss startup Synhelion is also targeting commercial operations at a synthetic-fuel plant in Germany in 2028. Robotics: A Swiss innovation is a flexible drone designed to withstand collisions with obstacles. AI Standards: Geneva-based standards organisations are weighing whether labels can help people judge the trustworthiness of AI-generated images.
Low-Carbon Construction: A Lucerne University of Applied Sciences study found electric machinery cut operating CO₂ emissions by 87% at a Basel construction site; a Lucerne pilot recorded an 83% drop. Collision-Ready Drones: ETH Zurich’s flexible FlexiQuad drone can absorb impacts and keep flying, reaching 80 km/h in tests and surviving collisions at nearly 25 km/h. Quantum and Particle Physics: Swiss research teams are advancing faster laser cooling for quantum computers, while a new physics machine at CERN could help probe the electron. Trustworthy AI: Geneva-based standards organisations are weighing how to verify AI-generated images, as new research explores faster, more reliable AI models for climate prediction.
Cloud Resilience: Microsoft’s global outage disrupted services in Switzerland and more than 70 countries before the company restored Outlook, Teams and other products. Trustworthy AI: Geneva-based standards organisations are weighing how labels could help people identify AI-generated photos. Swiss Innovation: A Swiss AI firm is developing tools to protect critical infrastructure, while ETH Zurich researchers are exploring how bacteria could help build living structures. Detection Research: A new Swiss method offers a way to better detect date-rape drugs.
AI and Infrastructure: Zurich-area startup Phylax Intelligence is using AI to spot threats to critical infrastructure, including floods, fires, cyberattacks and drones. Trust in Images: Geneva-based standards groups are weighing how labels and image-origin tools can help distinguish AI-generated pictures from real photos, while experts warn that labels alone cannot guarantee trust. Cloud Resilience: Microsoft restored Outlook and Teams after a global outage lasting more than a day; Swiss luxury group Richemont was among companies forced to delay financial results. Swiss Medtech: Dental-tech firm vVARDIS made its NYSE debut with a drill-free treatment designed to repair early tooth decay. Research Frontiers: ETH Zurich researchers are exploring how bacteria could serve as building materials for living architecture. A Swiss-developed method to detect the date-rape drug GHB also drew attention this week.
Digital Resilience: Microsoft’s Outlook, Teams and Copilot outage disrupted services in Switzerland and worldwide for more than a day. Recovery was underway Friday, but the company gave no timeline for a full fix; it blamed server problems, not a cyberattack. Cancer Research: Baar-based Novocure says a published analysis of its Phase 3 pancreatic cancer trial found clinically meaningful improvements in pain and quality of life alongside the trial’s previously reported survival benefit. Materials Science: Researchers from ETH Zurich and UC Berkeley developed a hydrogel surface that stays clear under extreme condensation by drawing droplets into a continuous film. Archaeology: A study led by University of Bern researcher Gino Caspari found chemical traces of cannabis use in hair from a 2,800-year-old Siberian tomb, pointing to an early use of the plant for its intoxicating effects. Supercomputing: Switzerland’s National Supercomputing Center helped develop OpenCHAMI, an open-source system now managing seven production clusters at Los Alamos National Laboratory.
Biotech: Basel-based Windward Bio raised $175 million in its Nasdaq IPO and reached a $1.07 billion valuation after shares opened above their offer price. Sanofi is investing another $50 million as Windward advances an antibody treatment for asthma and COPD. Living Materials: ETH Zurich researchers are exploring how bacteria could serve as building blocks for living architecture. Space Security: Geneva-based WISeSat.Space and SEALSQ are developing satellite cybersecurity that combines hardware-based trust with post-quantum cryptography, covering spacecraft, ground stations and user terminals. Swiss Startups: Dental-health company vVardis cut its planned US IPO by more than 12%, now aiming to raise up to $200 million.
Industrial Technology: Zurich-based ABB has replaced 60 drive units and eight rectifier sections at a major Chinese paper mill, modernizing a 28-year-old system without replacing its motors or cabling. The six-day shutdown finished ahead of schedule. Swiss Biotech: Basel-based Windward Bio raised $175 million in its US IPO, with Sanofi investing another $50 million. Its lead antibody is being tested for asthma and COPD, with the company aiming for less frequent dosing than existing treatments. Quantum Research: Researchers have developed faster laser cooling for quantum computers, while a new physics machine at CERN could help probe the electron’s secrets. Swiss Science: A new Swiss-developed method aims to improve detection of a drug used in drink-spiking cases. Broadcast Technology: SRG SSR has restored 98 FM frequencies across 33 sites, bringing analog radio back within reach of about 80% of Switzerland’s population.
Swiss Biotech: Addex spinout Neurosterix raised $105 million to advance its experimental schizophrenia drug toward Phase 2, building on a new approach to treating the condition. Forensic Science: Researchers in Switzerland have developed a new way to detect GHB, a date-rape drug; a newly identified biomarker may extend the period in which it can be found. Farm Tech: A Swiss startup is tackling methane emissions from cows, a persistent challenge for the country’s agriculture sector. Chip Design: Geneva-based STMicroelectronics introduced 600-volt gate drivers for motor systems used in appliances such as fans and pumps. Digital Infrastructure: Swiss broadband provider Quickline is modernizing its network with Harmonic’s virtualized platform, while a competitiveness ranking warns Switzerland is losing ground in digital technology and AI. Space Tech: Swiss firm SWISSto12 and Univity are working together on sovereign 5G infrastructure in space.
Quantum Computing: ETH Zurich researchers have built a quantum memory that stores information in tiny mechanical vibrations, giving quantum processors a more flexible way to handle data. Swiss Connectivity: Quickline is modernizing its broadband network with virtualized technology, aiming to simplify operations and extend managed services to regional providers. Drug Detection: A new Swiss method could improve detection of GHB, a drug used in drink-spiking assaults. Biotech: Addex spin-out Neurosterix raised $105 million to advance a schizophrenia drug into Phase 2 trials. Robotics: Swiss firm Xer Technologies unveiled a hybrid drone designed for naval surveillance and resupply. Startup Funding: Zurich-based Redalpine closed a $250 million fund to back European software and science startups.
Swiss Science: Researchers in Switzerland have developed a way to detect GHB, the so-called date-rape drug, more effectively, using a biomarker that may help identify exposure later. AI and Competitiveness: Switzerland has slipped in digital competitiveness as AI reshapes the rankings, while Swiss banks face growing pressure to keep pace with AI adoption. Swiss Tech: Zurich-based wealthtech firm Light Frame raised $5.1 million to modernise private-bank systems; Swiss company Xer Technologies also unveiled a hybrid drone for naval surveillance and resupply. Startup Funding: Swiss VC firm redalpine closed a $250 million fund to back European software and science startups.
Forensic Science: University of Zurich researchers analyzed 2,414 real-case urine samples to assess GHB-pentose, a biomarker that may remain detectable for up to three days—far longer than GHB itself. Startup Spotlight: Nebraska-based Grain Weevil won MassChallenge Switzerland’s 2026 LDC Impact Prize in Lausanne for a robot that tends grain bins without putting workers inside. Venture Capital: Swiss investor Redalpine closed its oversubscribed $250 million eighth fund to back 20 European science and software startups. Space Technology: Swiss company SWISSto12 passed a key design review for antennas on UNIVITY’s 5G demonstration satellite, a step toward direct-to-device connectivity. Quantum Security: SEALSQ and Swiss chip designer IC’Alps are advancing chip-level post-quantum protection for connected medical devices.
Diagnostics: Researchers have developed synthetic-DNA sensors aimed at improving tests for small molecules such as testosterone and serotonin. Quantum Security: Geneva-based SEALSQ plans to bring secure chips and post-quantum protections into quantum-computing systems. Startup Funding: Swiss fintech startup Light Frame raised more than $5 million, while redalpine closed a $250 million fund for European software and science companies. Space Technology: SWISSto12 passed a key design review for antennas for a Swiss-led 5G satellite demonstration. Robotics: Swiss firm ANYbotics has begun delivering its robot for use in explosive environments. Climate Science: A study found Alpine permafrost is thawing deeper each year; another linked human land use to sharply higher sediment in an Alpine lake and the conditions for two major tsunamis. Clean Computing: CERN’s Geneva-area data centre reuses 3MW of waste heat, with plans to raise that to 4MW. Soil Health: A Swiss pilot paid 55 farms about CHF1.6 million for carbon stored in agricultural soils, but broader adoption will need reliable funding.
Space Technology: Renens-based SWISSto12 has completed a key design review for antennas on UNIVITY’s planned 5G demonstration satellites, clearing the systems for flight-hardware production. Applied AI: Zurich Insurance’s internal generative AI assistant, ZuriChat, won a 2026 Qorus Award; it helps staff draft, summarize and analyze information. Risk Research: The University of St. Gallen is teaming up with South Korea’s insurance research institute to study risks from AI, self-driving vehicles and cyber threats. Davos Agenda: AI, jobs and geopolitical tensions are set to feature prominently at the World Economic Forum’s 2027 meeting in Davos. Alpine Science: Research points to deepening risks in the Swiss Alps, where permafrost is thawing and human land use has increased sediment in an Alpine lake, setting the stage for two catastrophic tsunamis.
Space Connectivity: Swiss startup SWISSto12 and France’s UNIVITY passed a design review for satellite antennas that could deliver both broadband and direct-to-phone 5G, moving their joint project closer to hardware production. Gene Editing: Zug-based CRISPR Therapeutics reported early trial results for a one-time treatment that cut triglycerides by an average of 63% after 30 days in patients with dangerously high levels. Biotech: Zemcelpro, a cell therapy for blood cancers, secured a European commercialization deal covering Switzerland and 31 other countries. Basel-based Windward Bio, developing antibody drugs for respiratory and skin diseases, also set terms for a US IPO seeking up to $185 million. Cybersecurity: Geneva-based SEALSQ and Swiss subsidiary IC’Alps are developing chip-level post-quantum protections for connected medical devices. AI and Finance: At the University of Zurich, Bank of England Governor Andrew Bailey warned that overvalued AI stocks could trigger a market bubble, and called for stronger testing and monitoring of AI systems. Telecom: Sunrise plans to let customers build tailored mobile plans through its AI assistant, Five, starting November 17.
Biotech: Avanzanite won European commercialisation rights for Zemcelpro, a stem-cell therapy for certain blood cancers. Its 32-country remit includes Switzerland, where the company plans to seek marketing approval. Quantum Research: ETH Zurich researchers found that two precisely timed laser pulses can move atomic layers in a quantum material more effectively than one stronger pulse, opening new ways to control its properties. Health Research: A major trial led by the University of Bern found that stopping statins was no worse than continuing them over two years for older adults with multiple conditions and no prior cardiovascular disease; longer follow-up showed a possible rise in risk, underscoring the need for individual decisions. Swiss Tech: China blocked SoftBank’s proposed $5.4 billion purchase of ABB’s robotics business, disrupting a major deal involving the Swiss engineering group. Startup Watch: Swiss dental-tech firm vVardis is targeting a US IPO valuation of up to $4.4 billion. Archaeology: A University of Bern researcher helped identify the oldest physical evidence of cannabis used for its intoxicating effects, in a 2,800-year-old Siberian burial site.
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.